Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-30
2005-08-30
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S517000, C548S527000, C548S541000, C548S543000, C546S278400, C514S422000, C514S424000
Reexamination Certificate
active
06936633
ABSTRACT:
The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
REFERENCES:
patent: WO 95/19362 (1995-07-01), None
Bertha et al., (1998) Tetrahedron, vol. 54(50), 15227-15242. (CA PLUS document No. 130:124913).
Dasse Olivier
Evans Janelle
Higgins Paul
Kintigh Jeremy
Knerr Laurent
McDonnell Boehnen & Hulbert & Berghoff LLP
Shameem Golam M M
UCB S.A.
LandOfFree
Pyrrolidinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3462869